BofA/Merrill Lynch Downgrades Rockwell Medical Technologies (RMTI) to Underperform

November 8, 2016 7:09 AM EST
Get Alerts RMTI Hot Sheet
Price: $5.89 -2.97%

Rating Summary:
    7 Buy, 2 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 9
Trade RMTI Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

BofA/Merrill Lynch downgraded Rockwell Medical Technologies (NASDAQ: RMTI) from Neutral to Underperform with a price target of $5.00.

For an analyst ratings summary and ratings history on Rockwell Medical Technologies click here. For more ratings news on Rockwell Medical Technologies click here.

Shares of Rockwell Medical Technologies closed at $5.66 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Merrill Lynch, Bank of America

Add Your Comment